Found: 5
Select item for more details and to access through your institution.
Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cardiac, Vascular and Hypertension Safety of Bosutinib vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia in the BFORE Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S294, doi. 10.1016/j.clml.2019.07.243
- By:
- Publication type:
- Article
Primary Results of the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase (CP) Chronic Myeloid Leukemia (CML).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S290, doi. 10.1016/j.clml.2019.07.235
- By:
- Publication type:
- Article
Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysis.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 6, p. 838, doi. 10.1007/s12185-022-03314-y
- By:
- Publication type:
- Article
Efficacy and safety of bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia in the Asian subpopulation of the phase 3 BFORE trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article